21.07.2013 Views

nr. 477 - 2011 - Institut for Natur, Systemer og Modeller (NSM)

nr. 477 - 2011 - Institut for Natur, Systemer og Modeller (NSM)

nr. 477 - 2011 - Institut for Natur, Systemer og Modeller (NSM)

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

2.3 Summary and Discussion 11<br />

triggers the autoimmune response that leads to T1D? 11<br />

One way of getting closer to a definitive answer to this could be through using a biomodel<br />

that was more akin to a human. Though bio-models have proven to be priceless<br />

assets in diabetes research it is important not to <strong>for</strong>get that they are models, and despite<br />

certain similarities the results obtained from these can not be directly interpreted in<br />

the frame of human physiol<strong>og</strong>y. Hopefully medical instruments will be so fine-tuned in<br />

the future that human pancreatic biopsies, that are too hazardous today (Notkins and<br />

Åke Lernmark (2001)), can be per<strong>for</strong>med with great benefit <strong>for</strong> the research society and<br />

so also diabetes patients.<br />

One could speculate that there are several subtypes of autoimmune diabetes, each<br />

associated by a specific trigger/event. In chapter 3 we will see how tentative treatments<br />

are sometimes, but not always, successful. An explanation <strong>for</strong> this fact could be that a<br />

treatment needs to be paired up with the right subtype of autoimmune diabetes.<br />

11 This is not only the case with T1D, but with a wide range of autoimmune diseases (Christen and<br />

von Herrath (2004)), of which T1D is one of the most common (Cantor and Haskins (2006)).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!